molsidomine has been researched along with sildenafil citrate in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jonas, U; Schultheiss, D; Stief, CG; Truss, MC | 1 |
Maisch, B | 1 |
Rehse, K; Reitner, N; Scheffler, H | 1 |
Andersson, K; Fujiwara, M; Persson, K | 1 |
Kang, TM; Lee, SW | 1 |
Andersen, CU; Mulvany, MJ; Simonsen, U | 1 |
Hashitani, H; Hayase, M; Kohri, K; Sasaki, S; Suzuki, H; Yanai, Y | 1 |
Gharib, S; Gonzalez-Cadavid, NF; Kovanecz, I; Nolazco, G; Rajfer, J; Rivera, S; Segura, D; Vernet, D | 1 |
Minaz, N; Pathak, L; Razdan, R | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 review(s) available for molsidomine and sildenafil citrate
Article | Year |
---|---|
[Pharmacological therapy in erectile dysfunction--current standards and new viewpoint].
Topics: Alprostadil; Dosage Forms; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Molsidomine; Muscle Relaxation; Muscle, Smooth; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Vasodilator Agents | 1997 |
10 other study(ies) available for molsidomine and sildenafil citrate
Article | Year |
---|---|
[Therapy recommendations for adverse effects of Viagra and nitrates (NO-donors)].
Topics: Angina Pectoris; Blood Pressure; Contraindications; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Molsidomine; Nicorandil; Nitrates; Nitric Oxide Donors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 1998 |
Interaction of Viagra with the NO donors molsidomine and RE 2047 with regard to antithrombotic and blood pressure lowering activities.
Topics: Animals; Arterioles; Blood Pressure; Drug Interactions; Fibrinolytic Agents; Hypertension; Molsidomine; Nitric Oxide Donors; Phosphodiesterase Inhibitors; Piperazines; Platelet Aggregation Inhibitors; Purines; Rats; Rats, Inbred SHR; Sildenafil Citrate; Sulfones; Sydnones; Thrombosis; Venules | 1999 |
Nitric oxide-induced cGMP accumulation in the mouse bladder is not related to smooth muscle relaxation.
Topics: Animals; Arginine; Carbachol; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Female; In Vitro Techniques; Mice; Mice, Inbred BALB C; Molsidomine; Muscle Relaxation; Muscle, Smooth; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Phosphodiesterase Inhibitors; Piperazines; Piperidines; Purines; Quinazolines; Sildenafil Citrate; Sulfones; Urethra; Urinary Bladder | 2000 |
[Erectile dysfunction. Help also for cardiac patients].
Topics: Apomorphine; Contraindications; Coronary Disease; Drug Interactions; Erectile Dysfunction; Humans; Male; Molsidomine; Nitrates; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2001 |
Effects of nitric oxide on the Ca2+-activated potassium channels in smooth muscle cells of the human corpus cavernosum.
Topics: Cells, Cultured; Drug Synergism; Electric Conductivity; Electrophysiology; Humans; Male; Molsidomine; Muscle, Smooth; Nitric Oxide; Nitric Oxide Donors; Penis; Piperazines; Potassium Channels; Potassium Channels, Calcium-Activated; Purines; Sildenafil Citrate; Sulfones | 2001 |
Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats.
Topics: Acetylcholine; Actins; Animals; Atrial Natriuretic Factor; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Guanylate Cyclase; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Lung; Male; Molsidomine; Muscle, Smooth; Oxadiazoles; Piperazines; Pulmonary Artery; Purines; Quinoxalines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Systole; Vasodilation; Vasodilator Agents | 2005 |
Role of nitric oxide/cyclic GMP pathway in regulating spontaneous excitations in detrusor smooth muscle of the guinea-pig bladder.
Topics: Action Potentials; Animals; Calcium; Cyclic GMP; Electrophysiology; Female; Guinea Pigs; In Vitro Techniques; Indoles; Isometric Contraction; Male; Molsidomine; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Piperazines; Purines; Signal Transduction; Sildenafil Citrate; Sulfones; Urinary Bladder | 2008 |
Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage.
Topics: Animals; Combined Modality Therapy; Impotence, Vasculogenic; Male; Mice; Molsidomine; Muscle Denervation; Muscle Fibers, Skeletal; Penile Erection; Penis; Piperazines; Purines; Rats; Rats, Inbred F344; Sildenafil Citrate; Stem Cell Transplantation; Sulfones; Vasodilator Agents | 2012 |
Repositioning of molsidomine for its efficacy in diabetes induced erectile dysfunction in rats: In silico, in vitro and in vivo approach.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus, Experimental; Drug Repositioning; Erectile Dysfunction; Female; Male; Molsidomine; Nitric Oxide Donors; Penile Erection; Penis; Protective Agents; Rats; Rats, Wistar; Sildenafil Citrate; Streptozocin; Testosterone | 2018 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |